Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Beximco Pharma (BXP)

Price 33.50p on 22-11-2024 at 17:30:02
Change 0.00p 0%
Buy 34.00p
Sell 33.00p
Buy / Sell BXP Shares
Last Trade: Buy 250,000.00 at 33.60p
Day's Volume: 266,638
Last Close: 33.50p
Open: 34.00p
ISIN: US0885792061
Day's Range 33.60p - 33.60p
52wk Range: 20.00p - 42.50p
Market Capitalisation: £150m
VWAP: 33.58802p
Shares in Issue: 446m

Recent Trades History Beximco Pharma (BXP)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 250,000 33.60p Suspected BUY Trade
14:00:02 - 22-Nov-24
Buy* 4,000 34.00p Ordinary
10:06:23 - 22-Nov-24
Sell* 10,000 33.26p Ordinary
09:44:54 - 22-Nov-24
Sell* 2,450 33.00p Ordinary
09:39:41 - 22-Nov-24
Buy* 188 34.00p Ordinary
09:25:49 - 22-Nov-24

Share Price History for Beximco Pharma

Time period:
to
Date Open High Low Close Volume

Share News for Beximco Pharma

Beximco Pharmaceuticals says full court hearing set for October 28

2nd Oct 2024 12:12

(Alliance News) - Beximco Pharmaceuticals Ltd on Wednesday said the Bangladesh court has referred the company's appeal in its recent fraud case to a full-court hearing, which will take place on October 28. Read More

IN BRIEF: Beximco Pharma vice-chair arrested for ties to ousted PM

15th Aug 2024 11:28

Beximco Pharmaceuticals - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Confirms that Vice-Chair Salman Rahman was arrested by Dhaka police on Tuesday and will be held for 10 days while an investigation into alleged offences is carried out. Rahman was a private industry and investment advisor to deposed Bangladesh prime minister Sheikh Hasina, who fled the country earlier this month amid accusations of human rights abuses. Read More

IN BRIEF: Beximco Pharma says Bangladesh unrest reduced distribution

13th Aug 2024 13:44

Beximco Pharmaceuticals Ltd - Dhaka-based generic pharmaceutical products and active ingredients manufacturer - Distribution of products was reduced in response to the recent civil unrest in Bangladesh, in the interest of employee safety, but it is now returning to normal levels. "The interim government of Bangladesh has indicated that it intends to address any ongoing unrest as a priority, and we expect to be able to resume normal distribution in the coming days," Beximco says. No significant damage was done to its manufacturing and distribution facilities, and the company says it doesn't expect the disruption to have a "material impact" on annual results. Read More

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue

30th Apr 2024 19:54

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Beximco names Iqbal Ahmed as managing director

4th Mar 2024 13:58

Beximco Pharmaceuticals Ltd - generic pharmaceutical products and active ingredients' manufacturer - Announces that Non-Executive Director Iqbal Ahmed has been appointed as Beximco's managing director for five years with immediate effect. This appointment is subject to approval of the shareholders, and follows the departure of Nazmul Hassan. According to Beximco, Ahmed is a "long-standing member of the Beximco Pharma Board" and has over 47 years business experience, including within the pharmaceutical sector. Read More

FTSE 100 Latest
Value8,262.08
Change112.81

Login to your account

Forgot Password?

Not Registered